Edition:
United Kingdom

IRLAB Therapeutics AB (IRLABa.ST)

IRLABa.ST on Stockholm Stock Exchange

88.90SEK
9:35am BST
Change (% chg)

-1.10kr (-1.22%)
Prev Close
90.00kr
Open
90.00kr
Day's High
90.00kr
Day's Low
88.80kr
Volume
2,477
Avg. Vol
15,983
52-wk High
98.00kr
52-wk Low
39.00kr

About

IRLAB Therapeutics AB is a Sweden-based research and development company. It focuses on illnesses in the central nervous system and primarily on development of drugs to assist patients with Parkinson’s disease. The Company possesses a research platform Integrative Screening Process (ISP), which aims to discover and develop drug... (more)
No analyst recommendations are available for .

Overall

Beta: --
Market Cap(Mil.): kr3,612.77
Shares Outstanding(Mil.): 40.14
Dividend: --
Yield (%): --

Financials

  IRLABa.ST Industry Sector
P/E (TTM): -- 32.51 37.25
EPS (TTM): -1.93 -- --
ROI: -44.95 12.52 12.15
ROE: -45.50 13.83 16.99

Earnings vs. Estimates